BioLife Solutions Statistics
Share Statistics
BioLife Solutions has 46.39M shares outstanding. The number of shares has increased by 6.09% in one year.
| Shares Outstanding | 46.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.15% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 45.21M |
| Failed to Deliver (FTD) Shares | 139 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 3.50M, so 7.55% of the outstanding shares have been sold short.
| Short Interest | 3.50M |
| Short % of Shares Out | 7.55% |
| Short % of Float | 7.75% |
| Short Ratio (days to cover) | 13.43 |
Valuation Ratios
The PE ratio is -10.69 and the forward PE ratio is -94.64.
| PE Ratio | -10.69 |
| Forward PE | -94.64 |
| PS Ratio | 4.96 |
| Forward PS | 10.3 |
| PB Ratio | 2.1 |
| P/FCF Ratio | -37.63 |
| PEG Ratio | n/a |
Enterprise Valuation
BioLife Solutions Inc. has an Enterprise Value (EV) of 717.69M.
| EV / Earnings | -10.8 |
| EV / Sales | 5.01 |
| EV / EBITDA | -15.86 |
| EV / EBIT | -10.13 |
| EV / FCF | -38.02 |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.86 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.08 |
| Total Debt / Capitalization | 7.74 |
| Cash Flow / Debt | -0.44 |
| Interest Coverage | -39.09 |
Financial Efficiency
Return on equity (ROE) is -0.2% and return on capital (ROIC) is -18.67%.
| Return on Equity (ROE) | -0.2% |
| Return on Assets (ROA) | -0.16% |
| Return on Capital (ROIC) | -18.67% |
| Revenue Per Employee | 350.30K |
| Profits Per Employee | -162.41K |
| Employee Count | 409 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.22 |
Taxes
| Income Tax | 169.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 78.39% in the last 52 weeks. The beta is 1.88, so BioLife Solutions 's price volatility has been higher than the market average.
| Beta | 1.88 |
| 52-Week Price Change | 78.39% |
| 50-Day Moving Average | 24.52 |
| 200-Day Moving Average | 21.9 |
| Relative Strength Index (RSI) | 57.29 |
| Average Volume (20 Days) | 386.24K |
Income Statement
In the last 12 months, BioLife Solutions had revenue of $143.27M and earned -$66.43M in profits. Earnings per share was $-1.52.
| Revenue | 143.27M |
| Gross Profit | 46.75M |
| Operating Income | -70.83M |
| Net Income | -66.43M |
| EBITDA | -45.24M |
| EBIT | -70.83M |
| Earnings Per Share (EPS) | -1.52 |
Balance Sheet
The company has $35.41M in cash and $42.69M in debt, giving a net cash position of -$7.28M.
| Cash & Cash Equivalents | 35.41M |
| Total Debt | 42.69M |
| Net Cash | -7.28M |
| Retained Earnings | -313.34M |
| Total Assets | 381.65M |
| Working Capital | 57.22M |
Cash Flow
In the last 12 months, operating cash flow was -$12.50M and capital expenditures -$6.38M, giving a free cash flow of -$18.88M.
| Operating Cash Flow | -12.50M |
| Capital Expenditures | -6.38M |
| Free Cash Flow | -18.88M |
| FCF Per Share | -0.43 |
Margins
Gross margin is 32.63%, with operating and profit margins of -49.43% and -46.36%.
| Gross Margin | 32.63% |
| Operating Margin | -49.43% |
| Pretax Margin | -46.25% |
| Profit Margin | -46.36% |
| EBITDA Margin | -31.58% |
| EBIT Margin | -49.43% |
| FCF Margin | -13.18% |
Dividends & Yields
BLFS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -5.7% |
| FCF Yield | -1.53% |
Analyst Forecast
The average price target for BLFS is $28, which is 5% higher than the current price. The consensus rating is "Buy".
| Price Target | $28 |
| Price Target Difference | 5% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Jan 29, 2014. It was a backward split with a ratio of 1:14.
| Last Split Date | Jan 29, 2014 |
| Split Type | backward |
| Split Ratio | 1:14 |
Scores
| Altman Z-Score | 12.19 |
| Piotroski F-Score | 5 |